Literature DB >> 19433984

Cardiomyocyte S1P1 receptor-mediated extracellular signal-related kinase signaling and desensitization.

Rong Tao1, Holly E Hoover, Jianqing Zhang, Norman Honbo, Conrad C Alano, Joel S Karliner.   

Abstract

We examined the ability of sphingosine-1-phosphate (S1P) to desensitize extracellular signal-related kinase (ERK), a mitogen-activated protein kinase linked to antiapoptotic responses in the heart. In isolated adult mouse cardiomyocytes, S1P (10 nM-5 microM) induced ERK phosphorylation in a time- and dose-dependent manner. S1P stimulation of ERK was completely inhibited by an S1P1/3 subtype receptor antagonist (VPC23019), by a Gi protein inhibitor (pertussis toxin) and by a mitogen-activated protein kinase/ERK kinase inhibitor (PD98059). A selective S1P3 receptor antagonist (CAY10444) had no effect on S1P-induced ERK activation. The selective S1P1 agonist SEW2871 also induced ERK phosphorylation. Activation of ERK by restimulation with 100 nM S1P was suppressed after 1 hour of preincubation with 100 nM S1P but recovered fully the next day, suggesting receptor recycling. Similar results were obtained in protein kinase C epsilon-null cardiomyocytes. Treatment with the nonselective S1P receptor agonist FTY720 for 1 hour also reduced phospho-ERK expression in response to subsequent S1P stimulation. In contrast to S1P, some desensitization to FTY720 persisted after overnight exposure. Cell death induced by hypoxia/reoxygenation was reduced by pretreatment with exogenous S1P. This enhanced survival was abrogated by pretreatment with PD98059, VPC23019, or pertussis toxin. Thus, exogenous S1P induces rapid and reversible S1P1-mediated ERK phosphorylation. S1P-induced adult mouse cardiomyocyte survival requires ERK activation mediated via an S1P1-Gi pathway.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19433984      PMCID: PMC2835551          DOI: 10.1097/FJC.0b013e3181a7b58a

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  60 in total

1.  Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients.

Authors:  Susan R Schwab; João P Pereira; Mehrdad Matloubian; Ying Xu; Yong Huang; Jason G Cyster
Journal:  Science       Date:  2005-09-09       Impact factor: 47.728

2.  Immunosuppressive and anti-angiogenic sphingosine 1-phosphate receptor-1 agonists induce ubiquitinylation and proteasomal degradation of the receptor.

Authors:  Myat Lin Oo; Shobha Thangada; Ming-Tao Wu; Catherine H Liu; Timothy L Macdonald; Kevin R Lynch; Chen-Yong Lin; Timothy Hla
Journal:  J Biol Chem       Date:  2007-01-21       Impact factor: 5.157

3.  Sphingosine 1-phosphate inhibits ischemia reperfusion injury following experimental lung transplantation.

Authors:  M Okazaki; F Kreisel; S B Richardson; D Kreisel; A S Krupnick; G A Patterson; A E Gelman
Journal:  Am J Transplant       Date:  2007-04       Impact factor: 8.086

4.  Mapping pathways downstream of sphingosine 1-phosphate subtype 1 by differential chemical perturbation and proteomics.

Authors:  Pedro J Gonzalez-Cabrera; Timothy Hla; Hugh Rosen
Journal:  J Biol Chem       Date:  2007-01-10       Impact factor: 5.157

5.  Adenosine triggers preconditioning through MEK/ERK1/2 signalling pathway during hypoxia/reoxygenation in neonatal rat cardiomyocytes.

Authors:  R Germack; J M Dickenson
Journal:  J Mol Cell Cardiol       Date:  2005-09       Impact factor: 5.000

6.  Phosphodiesterase-5 inhibitor sildenafil preconditions adult cardiac myocytes against necrosis and apoptosis. Essential role of nitric oxide signaling.

Authors:  Anindita Das; Lei Xi; Rakesh C Kukreja
Journal:  J Biol Chem       Date:  2005-01-24       Impact factor: 5.157

7.  High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia/reperfusion injury in vivo via the S1P3 lysophospholipid receptor.

Authors:  Gregor Theilmeier; Christoph Schmidt; Jörg Herrmann; Petra Keul; Michael Schäfers; Ilka Herrgott; Jan Mersmann; Jan Larmann; Sven Hermann; Jörg Stypmann; Otmar Schober; Reinhard Hildebrand; Rainer Schulz; Gerd Heusch; Michael Haude; Karin von Wnuck Lipinski; Christine Herzog; Martina Schmitz; Raimund Erbel; Jerold Chun; Bodo Levkau
Journal:  Circulation       Date:  2006-09-18       Impact factor: 29.690

8.  Selective sphingosine 1-phosphate 1 receptor activation reduces ischemia-reperfusion injury in mouse kidney.

Authors:  Alaa S Awad; Hong Ye; Liping Huang; Li Li; Frank W Foss; Timothy L Macdonald; Kevin R Lynch; Mark D Okusa
Journal:  Am J Physiol Renal Physiol       Date:  2006-01-10

9.  Deletion of the sphingosine kinase-1 gene influences cell fate during hypoxia and glucose deprivation in adult mouse cardiomyocytes.

Authors:  Rong Tao; Jianqing Zhang; Donald A Vessey; Norman Honbo; Joel S Karliner
Journal:  Cardiovasc Res       Date:  2007-01-23       Impact factor: 10.787

10.  Peroxynitrite activates ERK via Raf-1 and MEK, independently from EGF receptor and p21Ras in H9C2 cardiomyocytes.

Authors:  B Pesse; S Levrand; F Feihl; B Waeber; B Gavillet; P Pacher; L Liaudet
Journal:  J Mol Cell Cardiol       Date:  2005-05       Impact factor: 5.000

View more
  16 in total

1.  LPS and palmitate synergistically stimulate sphingosine kinase 1 and increase sphingosine 1 phosphate in RAW264.7 macrophages.

Authors:  Junfei Jin; Zhongyang Lu; Yanchun Li; Ji Hyun Ru; Maria F Lopes-Virella; Yan Huang
Journal:  J Leukoc Biol       Date:  2018-06-08       Impact factor: 4.962

2.  High-density lipoprotein determines adult mouse cardiomyocyte fate after hypoxia-reoxygenation through lipoprotein-associated sphingosine 1-phosphate.

Authors:  Rong Tao; Holly E Hoover; Norman Honbo; Mikaila Kalinowski; Conrad C Alano; Joel S Karliner; Robert Raffai
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-01-08       Impact factor: 4.733

Review 3.  Sphingosine kinase and sphingosine 1-phosphate in the heart: a decade of progress.

Authors:  Joel S Karliner
Journal:  Biochim Biophys Acta       Date:  2012-06-23

4.  The immunosuppressant FTY720 prolongs survival in a mouse model of diet-induced coronary atherosclerosis and myocardial infarction.

Authors:  Guanying Wang; Roy Y Kim; Isabella Imhof; Norman Honbo; Fu Sang Luk; Kang Li; Nikit Kumar; Bo-Qing Zhu; Delphine Eberlé; Daniel Ching; Joel S Karliner; Robert L Raffai
Journal:  J Cardiovasc Pharmacol       Date:  2014-02       Impact factor: 3.105

5.  Sphingosine-1-phosphate receptor-3 signaling up-regulates epidermal growth factor receptor and enhances epidermal growth factor receptor-mediated carcinogenic activities in cultured lung adenocarcinoma cells.

Authors:  Andrew Hsu; Wenliang Zhang; Jen-Fu Lee; Jin An; Prasanna Ekambaram; Jingjing Liu; Kenneth V Honn; Carolyn M Klinge; Menq-Jer Lee
Journal:  Int J Oncol       Date:  2012-02-16       Impact factor: 5.650

6.  S1P lyase: a novel therapeutic target for ischemia-reperfusion injury of the heart.

Authors:  Padmavathi Bandhuvula; Norman Honbo; Guan-Ying Wang; Zhu-Qiu Jin; Henrik Fyrst; Meng Zhang; Alexander D Borowsky; Lisa Dillard; Joel S Karliner; Julie D Saba
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-02-18       Impact factor: 4.733

Review 7.  Implication of sphingosin-1-phosphate in cardiovascular regulation.

Authors:  Ningjun Li; Fan Zhang
Journal:  Front Biosci (Landmark Ed)       Date:  2016-06-01

8.  Sphingolipids in cardiovascular and cerebrovascular systems: Pathological implications and potential therapeutic targets.

Authors:  Masahito Kawabori; Rachid Kacimi; Joel S Karliner; Midori A Yenari
Journal:  World J Cardiol       Date:  2013-04-26

9.  PLCε, PKD1, and SSH1L transduce RhoA signaling to protect mitochondria from oxidative stress in the heart.

Authors:  Sunny Y Xiang; Kunfu Ouyang; Bryan S Yung; Shigeki Miyamoto; Alan V Smrcka; Ju Chen; Joan Heller Brown
Journal:  Sci Signal       Date:  2013-12-17       Impact factor: 8.192

10.  The clinically-tested S1P receptor agonists, FTY720 and BAF312, demonstrate subtype-specific bradycardia (S1P₁) and hypertension (S1P₃) in rat.

Authors:  Ryan M Fryer; Akalushi Muthukumarana; Paul C Harrison; Suzanne Nodop Mazurek; Rong Rhonda Chen; Kyle E Harrington; Roger M Dinallo; Joshua C Horan; Lori Patnaude; Louise K Modis; Glenn A Reinhart
Journal:  PLoS One       Date:  2012-12-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.